AKBA icon

Akebia Therapeutics
AKBA

Overview Fund Activity

156 hedge funds and large institutions have $391M invested in Akebia Therapeutics in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 23 reducing their positions, and 19 closing their positions.

Holders
156
Holders Change
+12
Holders Change %
+8.33%
% of All Funds
2.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
76
Reduced
23
Closed
19
Calls
$1.97M
Puts
$1.23M
Net Calls
+$748K
Net Calls Change
+$1.28M

Top Buyers

1
BlackRock
1
BlackRock
New York
$66.9M
2
MB
2
MPM BioImpact
Massachusetts
$10.5M
3
Morgan Stanley
3
Morgan Stanley
New York
$19.4M
4
NL
4
Nuveen LLC
North Carolina
$9.86M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$53.2M

Top Sellers

1
GPP
1
Great Point Partners
Connecticut
$7.23M
2
ACM
2
AIGH Capital Management
Maryland
$0
3
WP
3
Woodline Partners
California
$3.64M
4
Citadel Advisors
4
Citadel Advisors
Florida
$8.43M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$33.3K
Name Market Value Shares Shares
Change 		Shares
Change %
Northwestern Mutual Wealth Management
176
Northwestern Mutual Wealth Management
Wisconsin
– – -5 Closed
Group One Trading
177
Group One Trading
Illinois
– – – –
4 5 6 7
8